iScience (Aug 2024)

Case-control study on post-COVID-19 conditions reveals severe acute infection and chronic pulmonary disease as potential risk factors

  • Pritha Ghosh,
  • Michiel J.M. Niesen,
  • Colin Pawlowski,
  • Hari Bandi,
  • Unice Yoo,
  • Patrick J. Lenehan,
  • Praveen Kumar-M,
  • Mihika Nadig,
  • Jason Ross,
  • Sankar Ardhanari,
  • John C. O’Horo,
  • A.J. Venkatakrishnan,
  • Clifford J. Rosen,
  • Amalio Telenti,
  • Ryan T. Hurt,
  • Venky Soundararajan

Journal volume & issue
Vol. 27, no. 8
p. 110406

Abstract

Read online

Summary: Post-COVID-19 conditions (long COVID) has impacted many individuals, yet risk factors for this condition are poorly understood. This retrospective analysis of 88,943 COVID-19 patients at a multi-state US health system compares phenotypes, laboratory tests, medication orders, and outcomes for 1,086 long-COVID patients and their matched controls. We found that history of chronic pulmonary disease (CPD) (odds ratio: 1.9, 95% CI: [1.5, 2.6]), migraine (OR: 2.2, [1.6, 3.1]), and fibromyalgia (OR: 2.3, [1.3, 3.8]) were more common for long-COVID patients. During the acute infection phase long COVID patients exhibited high triglycerides, low HDL cholesterol, and a high neutrophil-lymphocyte ratio; and were more likely hospitalized (5% vs. 1%). Our findings suggest severity of acute infection and history of CPD, migraine, chronic fatigue syndrome (CFS), or fibromyalgia as risk factors for long COVID. These results suggest that suppressing acute disease severity proactively, especially in patients at high risk, can reduce incidence of long COVID.

Keywords